WellMedr vs yourEra

What we like

• A real low-dose line rather than a smaller pour of the standard plan: eight microdose formulations, four oral and four injectable, built on tirzepatide or semaglutide with NAD+, B12, inositol, methionine, L-carnitine or magnesium depending on the SKU — the needle-free half of that matters if injections are the thing that has kept you from starting
• Both molecules plus an FDA-approved brand path priced on the same page — Ozempic from $1,399/mo and Zepbound from $1,599/mo, both month-to-month — so a woman whose clinician wants brand rather than compounded can see the cash cost without opening another tab
• Tirzepatide is priced the same at every dose: "Same price regardless of dosage" is printed on that plan card, so titrating up to a dose that works does not raise the bill — the question a woman starting low should be asking, and one most of this ranking leaves unanswered

The caveats

• –The headline is not a rate you can hold. The semaglutide card is titled "Monthly Plan", reads "Starting At $59 a month" and is subtitled "Best for flexibility" — while the banner across the top of the same page reads "Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life". Nothing on the page reconciles the two, and there is no term selector to check
• –No standing month-to-month price is published for either compounded molecule, anywhere. Both plan buttons hand you to intake.wellmedr.com, an intake app that serves no price in its own HTML, so the figure you would actually be charged does not exist on the public site — you meet it after the medical intake
• –A "month" here is not a month, and the site gives two different answers about which one it is: the plan cards say medication is "shipped every 4 weeks", which is thirteen shipments a year, while the refund and cancellation policy says the subscription "will automatically renew every 21 days", which is more than seventeen. Either way you are billed more often than the monthly label implies

What we like

• Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
• Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
• Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted

The caveats

• –Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
• –Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
• –Injectable only — no oral route and no brand-name lane